Keyphrases
Severe Combined Immunodeficiency
77%
DNA Damage Response
68%
DNA Double-strand Breaks
63%
B Cells
60%
Primary Immune Deficiency
53%
Hematopoietic Cell Transplantation
53%
Lymphocytes
46%
Pediatric Patients
44%
Double-strand Breaks
44%
Chronic Granulomatous Disease
34%
DNA Breaks
34%
Pre-B Cells
31%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
30%
Ataxia Telangiectasia mutated
29%
B Cell Development
27%
DNA Damage Signaling
27%
Antigen Receptor
25%
Replication Stress
25%
Genotoxicity
25%
APOBEC3A
25%
Structural Maintenance of Chromosomes
25%
Chromosome 5
25%
Bz-423
25%
Newborn Screening
24%
Physiologic
24%
Immune Reconstitution
23%
Lymphocyte Development
23%
Hematopoietic Cell Transplant
19%
Genotype
19%
Hematopoietic Stem Cell Transplantation
18%
Tetraspanin
17%
CD53
17%
Infection Diagnosis
17%
Infection Prophylaxis
17%
Hemophagocytic Lymphohistiocytosis
17%
Host Cell
17%
Secreted Proteins
17%
Toxoplasma
17%
Benzodiazepines
17%
Malignant Disorders
17%
Alemtuzumab
17%
T Cells
16%
Type-specific
16%
V(D)J Recombination
16%
Antigen Receptor Loci
16%
Graft-versus-host Disease (GvHD)
15%
G1 Phase
15%
Hematopoietic Stem Cell Transplant
15%
Apoptosis
14%
Interleukin-7 (IL-7)
14%
Immunology and Microbiology
B Cell
100%
Severe Combined Immunodeficiency
70%
DNA Damage Response
68%
Hematopoietic Cell
65%
Double-Strand DNA Break
53%
Immunodeficiency
48%
Cell Transplantation
46%
T Cell
45%
Lymphocyte
43%
Hematopoietic Stem Cell Transplantation
36%
Chronic Granulomatous Disease
34%
Immune Reconstitution
27%
Ataxia Telangiectasia
26%
Conditioning
25%
Newborn Screening
24%
Programmed Cell Death
23%
Lymphocyte Development
23%
DNA Damage
22%
Receptor Gene
18%
Lymphocytopenia
18%
B Cell Development
17%
Tetraspanin
17%
Hemophagocytic Lymphohistiocytosis
17%
Alemtuzumab
17%
Cell Death
17%
Intravenous Immunoglobulin
16%
Overall Survival
15%
V(D)J Recombination
15%
Nuclease
15%
Cell Cycle G1 Phase
14%
Immunity
13%
Immune Response
12%
Lymphocyte Proliferation
12%
B-Cell Receptor
11%
Cell Survival
11%
Maturation
11%
Graft-Versus-Host Disease
11%
Neutrophil
11%
Superoxide
10%
Transcription Factors
10%
Immunodeficiency
10%
Cell Cycle
10%
Cytokine
9%
Lymphopoiesis
9%
Developmental Stage
9%
Engraftment
9%
Phytohaemagglutinin
8%
CXCR4
8%
Adenosine Deaminase
8%
Probiotic
8%
Medicine and Dentistry
Hematopoietic Cell
55%
Severe Combined Immunodeficiency
54%
Immune Deficiency
45%
Cell Transplantation
38%
B Cell
37%
Infection
33%
Transplantation
32%
Pediatrics Patient
25%
Hematopoietic Stem Cell Transplantation
25%
Lymphocyte
24%
Newborn Screening
24%
Programmed Cell Death
21%
Diseases
21%
DNA Damage Response
19%
Chronic Granulomatous Disease
17%
Lymphocyte Development
17%
Benzodiazepine
17%
T Cell
16%
Lymphocyte Antigen Receptor
16%
Ataxia Telangiectasia
14%
Pediatrics
12%
Cell Therapy
11%
Disease
11%
Receptor
11%
Superoxide
10%
Neonatal Infant
10%
Cytokine
9%
Overall Survival
9%
Cell Death
8%
Tetraspanin
8%
Antivirus Agent
8%
Maturation
8%
Leukemogenesis
8%
Hemophagocytic Lymphohistiocytosis Syndrome
8%
Clinical Immunology
8%
Immune Reconstitution
8%
Hemophagocytic Syndrome
8%
Alternative RNA Splicing
8%
Acute Myeloid Leukemia
8%
Natural Killer Cell
8%
Oxidoreductase
8%
Assessment Factor
8%
Arm
8%
Lymphopoiesis
8%
Lymphocytosis
8%
Male Infertility
8%
Tertiary Care
8%
Thiamine
8%
Kinase
8%
Hypoplasia
8%